Proteus Biomedical Inc.
This article was originally published in Start Up
Executive Summary
Proteus Biomedical Inc. is developing a suite of proprietary MEMS-based technologies for congestive heart failure. It is staking its first claim in the fast-growing cardiac resynchronization therapy market.